Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies - Wikidata - wikimedia - TriplyDB

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies

http://www.wikidata.org/entity/Q26769957

about

Therapies for Prevention and Treatment of Alzheimer's Disease Confocal Spectroscopy to Study Dimerization, Oligomerization and Aggregation of Proteins: A Practical Guide Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease Glial contributions to neurodegeneration in tauopathies.Monoaminergic neuropathology in Alzheimer's disease.Potential mechanisms and implications for the formation of tau oligomeric strains.Biomarkers of Traumatic Brain Injury: Temporal Changes in Body Fluids New Opportunities and Challenges of Smart Polymers in Post-Translational Modification Proteomics.Design and Development of a Novel Chalcone Derivative as an Anticholinesterase Inhibitor for Possible Treatment of Dementia.Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease Augmenting autophagy for prognosis based intervention of COPD-pathophysiology.Perspective Insights of Exosomes in Neurodegenerative Diseases: A Critical Appraisal.Rebalancing β-Amyloid-Induced Decrease of ATP Level by Amorphous Nano/Micro Polyphosphate: Suppression of the Neurotoxic Effect of Amyloid β-Protein Fragment 25-35.Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat.Master Autophagy Regulator Transcription Factor EB Regulates Cigarette Smoke-Induced Autophagy Impairment and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis.Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.Oxygen and Glucose Deprivation Alter Synaptic Distribution of Tau Protein: The Role of Phosphorylation.A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases.Small-molecule PET Tracers for Imaging Proteinopathies.Understanding Miro GTPases: Implications in the Treatment of Neurodegenerative Disorders.EuroTau: towing scientists to tau without tautology.Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid.Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers.Tau protein liquid-liquid phase separation can initiate tau aggregation.Comparing the Folds of Prions and Other Pathogenic Amyloids.The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome.Phosphorylation of different tau sites during progression of Alzheimer's disease.A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicity Minimotifs dysfunction is pervasive in neurodegenerative disorders A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer's Disease Inflammation as a central mechanism in Alzheimer's disease Integration of Biomarkers Into a Signature Profile of Persistent Traumatic Brain Injury Involving Autoimmune Processes Following Water Hammer Injury From Repetitive Head Impacts Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay

P2860

Q26740007-737BEB0D-8614-4485-A631-FC5695CBF8CB Q26752808-458A7BCA-0BAC-4A15-9088-43B4EA314845 Q28074504-70C6A4E4-F94F-4778-AB29-2DBC713F5ECC Q32173558-3EA582D2-96D1-4591-9002-2193AC75C63C Q38809649-E7C102BB-2593-4C36-8835-8433A524A1E0 Q38960046-3E20DE93-B20A-4E29-AF9B-D7997CA55D63 Q39061827-B82B38AF-430E-4E24-8237-C692DAF7D4DF Q39098842-6BDA6AF5-FA31-4105-A3A4-DC053446973A Q41036141-D8CE1435-C7F0-4D77-ACA4-28D6A8714A3B Q41971448-B4427A3C-06BC-4295-B575-FB8C39DF8A0A Q42354703-F2D087CE-A1BF-4C98-8ECD-20900406E0BF Q42369812-F1A54BED-8289-4FCE-A0B5-EE6B0FDD857A Q43227037-B6ECC00E-4C95-4ED8-A743-C2E82405A312 Q46237544-90FF4436-A899-45EE-AB90-32FB3F5F012C Q46460982-DF00A268-CA21-48FE-8C70-304862407DCB Q47414857-25FD6CFD-6376-4E60-87D7-EF22E08362FF Q47860725-9FF19CA9-AEC9-4706-87E4-48CA733F7BE6 Q47891276-479DBF98-CF82-486D-9A89-081AA86E240B Q47926474-899A8EA1-5264-4221-87FF-EA7E04AD8235 Q48092663-F2D966DF-40B0-45AB-851D-943A147408E2 Q48215823-C1042253-A401-479A-BBA4-A2727A414778 Q48425790-D6CC6826-A990-4132-9616-3D8E512FC28D Q52598834-0240C2F5-E7BC-416C-86A1-17D8D2CE3413 Q53395943-D1063B2B-FA99-4542-ADCD-F451272AE79F Q53397941-9AC3A6D4-D5A2-4E36-BD29-C56F732D4F65 Q54977801-3483E264-DACB-4CC8-B19B-8F4EFDFD4A01 Q55109555-F8C5F3BE-23B7-40E5-AABB-69B9FDCC2E97 Q55517090-D0CDDD5C-26A2-448B-903B-F890B954F104 Q57061905-B45C8F02-FE05-40C8-A129-2A873B120D91 Q57174649-145E0120-9140-4A9E-AEC1-2A284D1EBB68 Q57927766-DFE23C2E-0D09-4954-86B2-4C5171B9E900 Q58555818-55637E7D-635D-4785-9FE3-1CE3E413932F Q58596203-26C1D6DA-722D-4EAE-828D-E332F72B85D0 Q58696563-BC476691-62DB-45C3-81A1-9DD9FDE0BF94

P2860

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies

http://www.wikidata.org/entity/Q26769957

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies

@ast

Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies

@en

Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies

@nl

type

label

Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies

@ast

Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies

@en

Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies

@nl

prefLabel

Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies

@ast

Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies

@en

Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies

@nl

P1433

Q26769957-897B07AD-919B-4035-A18B-AE41528001D4

P1476

Q26769957-69BD1838-C167-4B20-B60F-A94A4581EA25

P2093

Q26769957-44B5CAA7-9524-4ACD-9F5C-6EB0D7B2564E

Q26769957-597A8CD9-C5E1-4A0C-A21A-B738ADCC22B9

Q26769957-6EC7AF4F-972A-436D-A10C-81EB4F709A43

Q26769957-775D8410-3715-45FB-840E-7C12426F3186

Q26769957-984923DB-690B-46EC-B2C7-61CB4630F2C1

P275

Q26769957-DEEC0D22-7303-425A-8102-74D72ADFF6A8

P2860

Q26769957-0131219A-444F-4C11-B512-91DC5A2B2920

Q26769957-01629E24-E570-46E9-ACA5-05A2E3B113ED

Q26769957-01FD5973-D19B-4A03-8A42-05E8104EEAFE

Q26769957-07A51B77-CD89-44A8-8B8E-BD961BF2BCE2

Q26769957-093AB05A-4084-4F3C-AEE0-5DE5AC972AD9

Q26769957-0C6F6B23-20F3-4168-B703-7874B8F6C510

Q26769957-0F7B493A-C7E3-49A0-B759-2E3889906A95

Q26769957-0FE6ADD0-A967-436B-90D0-8A35515BA6D5

Q26769957-10C6EF78-DE16-415F-9748-0730A75CE6E0

Q26769957-12EE021D-77C1-4D51-A47F-CFF99D34277B

P304

Q26769957-6CE6EF17-590B-449D-AA4D-251A789B3880

P31

Q26769957-B89B6340-5C0F-4D2B-8F25-0025B61C05B4

Q26769957-B9657DEC-E507-4307-A050-72420783C368

P3181

Q26769957-484FAADB-85B0-46F8-AD93-1D1377B0B19E

P356

Q26769957-F417EADF-8AFD-45E5-B654-14EDED2863C7

P407

Q26769957-482A0DA3-23FC-4579-A7C8-0CC3D3FDDD52

P433

Q26769957-CBCC9E37-2418-4EF3-A6C4-259A73058837

P478

Q26769957-95C85EC7-439F-4B9F-BB97-06E17235D9A4

P50

Q26769957-2954EEFA-E4CB-4BBF-BD02-0D42D4EC1035

Q26769957-4F2831E0-690E-406A-AC43-B2AE123C6CD8

Q26769957-9900CFDB-2A41-466A-B554-4FB66E8FE3E9

Q26769957-9A1B9F79-B99E-41F0-8354-1A7CE2C7E067

Q26769957-9EC1A31D-111C-49E8-B102-D3254D26D92B

Q26769957-E9C57580-2341-40C6-BA44-E88512E460A5

Q26769957-FF2D7377-B88B-408B-81AF-6EFE8F91E7D2

P5008

Q26769957-CE362B1D-D078-4E23-A24E-D7E665DC3A09

P577

Q26769957-55A80EDA-E08E-4E56-A45F-BF17BB0FFDCC

P5875

Q26769957-C05A968F-1EB8-4C64-8054-09347882D2CE

P698

Q26769957-769B81D0-4693-424F-B94F-4DA44B1BE112

P921

Q26769957-4B469C95-4B66-408E-BDBF-6B2125F6D630

Q26769957-7B2C5B9C-1C83-4D59-BA28-F5B00CA7A4F8

Q26769957-8BF27C13-B01E-46A0-A1B8-0ADAE4B5D046

Q26769957-9116E875-10BD-4E17-92FF-F467592F3393

Q26769957-C666C844-7714-40C5-84D9-71CF7F2718C5

Q26769957-F7C312CF-67BD-4FC2-869E-F3F614AA98CB

P932

Q26769957-C619EB41-8ED1-42EB-BFC1-96255F572049

P3181

P356

P1433

P1476

Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies

@en

P2093

Claude Wischik

http://www.w3.org/2001/XMLSchema#string

Danira Bažadona

http://www.w3.org/2001/XMLSchema#string

Patrick R Hof

http://www.w3.org/2001/XMLSchema#string

Rohan de Silva

http://www.w3.org/2001/XMLSchema#string

Selina Wray

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

A protein factor essential for microtubule assembly

Complex Disposition of Methylthioninium Redox Forms Determines Efficacy in Tau Aggregation Inhibitor Therapy for Alzheimer's Disease

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

TREM2 Variants in Alzheimer's Disease

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

Tau-aggregation inhibitor therapy for Alzheimer's disease

Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain

ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

Histone deacetylase 6 interacts with the microtubule-associated protein tau

P304

6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1968072

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/BIOM6010006

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Nataša Jovanov-Milošević

Giuseppe Di Giovanni

Charles Harrington

Mirjana Babić Leko

P5008

P577

2016-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

289569412

http://www.w3.org/2001/XMLSchema#string

P698

26751493

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

membrane proteins

cytoskeletal proteins

nerve tissue proteins

P932

4808800

http://www.w3.org/2001/XMLSchema#string